Form 483

Mindray DS USA, Inc. dba Mindray North America Form 483, 2012-08-02

FDA issued a Form 483 to Mindray DS USA, Inc. dba Mindray North America on 2012-08-02 with 9 public-safe observations.

483· Form 483 issued9 observations

Mindray DS USA, Inc. dba Mindray North America · Mahwah, United States · Issued August 2, 2012

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Aug 2012
21 CFR 803.17(b)(1)

Info evaluated to determine if event was reportable

Cited by Li Li

2 Aug 2012
21 CFR 803.50(a)(1)

Report of Death or Serious Injury

Cited by Li Li

2 Aug 2012
21 CFR 806.10(a)(2)

Report of violation of the Act (see 803.52(e)(9))

Cited by Li Li

2 Aug 2012
21 CFR 820.30(g)

Design validation - software validation not performed

Cited by Li Li

2 Aug 2012
21 CFR 820.30(h)

Incorrect translation to production specifications

Cited by Li Li

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.17(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 803.50(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 806.10(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.198(c)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.30(h)Cited across public-safe Form 483 observations1x
21 CFR 820.72(a)Cited across public-safe Form 483 observations1x
21 CFR 820.90(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere